Tumor Necrosis Factor Alpha (TNF-α): Key Concepts

TNF-α is a crucial pro-inflammatory cytokine with diverse effects on the immune system, mediated through TNFR1 and TNFR2. While essential for host defense, excessive TNF-α contributes to chronic inflammatory diseases, making it a key target for therapeutic intervention using anti-TNF-α therapies.

TNF-α is a potent pro-inflammatory cytokine primarily produced by macrophages, but also by T cells, NK cells, and other immune cells. Its primary function is to regulate immune cells, induce inflammation, and initiate apoptosis (programmed cell death) under certain conditions, playing a crucial role in host defense against pathogens.

TNF-α signals through two main receptors, TNFR1 (also known as p55 or CD120a) and TNFR2 (p75 or CD120b), found on various cell types. TNFR1 is ubiquitously expressed and can mediate both apoptotic and inflammatory signals, while TNFR2 is primarily expressed on immune cells and plays a more prominent role in immune modulation and T cell activation.

The biological effects of TNF-α are diverse and context-dependent, ranging from beneficial roles in clearing infections to detrimental effects in chronic inflammatory diseases. In acute infections, TNF-α promotes recruitment of immune cells to the site of infection and enhances their activity, but prolonged or excessive TNF-α production contributes to tissue damage and systemic inflammation, leading to conditions like septic shock.

Due to its central role in inflammation, TNF-α is a major therapeutic target for various autoimmune and inflammatory disorders. Anti-TNF-α therapies, such as monoclonal antibodies (e.g., infliximab, adalimumab) and soluble receptors (e.g., etanercept), are widely used to treat conditions like rheumatoid arthritis, Crohn's disease, and psoriasis by blocking TNF-α's inflammatory effects.

Browse public study notes